An active substance binds to its cellular target structure. Credit: Daniel Rauh About 1,200 Germans are diagnosed with gastrointestinal stromal tumors every year—a rare type of cancer in which the tumors develop in the walls of the digestive organs and quickly develop resistance to common precision drugs. Scientists at TU Dortmund University, the West German...